CURX (Curanex Pharmaceuticals) Bathi saben saham sajrone patang kuartal pungkasan

Curanex Pharma (CURX) - logo korporat

This chart of EPS (TTM) value changes on the GURU.Markets platform for Curanex Pharmaceuticals Inc (CURX) is -836.50. Curanex Pharmaceuticals Inc (CURX) aims to outperform its capital rivals in biomarker validation. The business is vulnerable to component supply chain disruptions and complexities regarding international software patenting. Success depends on recognition from gastroenterologists and reaching critical milestones in the development of digestive organ medications.

Bathi resik saben saham sajrone 12 wulan pungkasan Curanex Pharmaceuticals Inc (CURX): kanggo periode 23.11.2025 - 18.11.2026

Curanex Pharmaceuticals Inc - rincian analitis lan metrik utama (CURX)

- rega pasar lan target rega analis:
- indikator valuasi pasar bisnis:
Analisis wiwitan perusahaan:Curanex Pharma, CURX
Sampel barang Curanex

For Curanex Pharmaceuticals Inc (CURX), expansion into the GI segment and the development of the drug pipeline are directly reflected in the EPS YoY (TTM) percentage growth history, which visualizes the earnings per share trend. This indicator compares current net income with the same period last year while accounting for currency fluctuations, allowing investors to assess the real efficiency of business scaling and avoid overpaying for the asset.